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The precise role of Leishmania glycoconjugate molecules including phosphoglycans (PGs) and lipophospho-
glycan (LPG) on host cellular responses is still poorly defined. Here, we investigated the interaction of
Leishmania major LPG2 null mutant (lpg2), which lacks both PGs and LPG, with dendritic cells (DCs) and
the subsequent early immune response in infected mice. Surprisingly, the absence of phosphoglycans did not
influence expression pattern of major histocompatibility complex class II (MHC II), CD40, CD80, and CD86
on DCs in vitro and in vivo. However, lpg2 L. major induced significantly higher production of interleukin-
12p40 (IL-12p40) by infected bone marrow-derived DCs (BMDCs) than wild-type (WT) parasites in vitro.
Furthermore, the production of IL-12p40 by draining lymph node cells from lpg2 mutant-infected mice was
higher than those fromWT L. major-infected mice. In model antigen presentation experiments, DCs from lpg2
mutant-infected mice induced more gamma interferon (IFN-) and IL-2 production by Leishmania-specific T
cells than those from WT-infected mice. Lymphocytes isolated from mice infected for 3 days with lpg2
parasites produce similar levels of IFN-, but significantly less IL-4 and IL-10 than WT controls. Decreased
IL-4 production was also seen in another general PG-deficient mutant lacking the Golgi UDP-galactose
transporters (lpg5A lpg5B), but not with the lpg1 mutant lacking only LPG, thereby implicating PGs
generally in the reduction of IL-4 production. Thus, Leishmania PGs influence host early immune response by
modulating DC functions in a way that inhibits antigen presentation and promotes early IL-4 response, and
their absence may impact the balance between Th1 and Th2 responses.
Leishmania species are the causative agents of the zoonotic
disease leishmaniasis, which is prevalent in six continents and
considered endemic in 88 countries. According to the WHO,
more than 12 million people are currently suffering from leish-
maniasis and a population of over 350 million are at risk of
contracting the disease (14, 15). Human cutaneous leishman-
iasis is caused by members of the Leishmania major subspecies
and is the most common form of the disease. Various forms of
pentavalent antimonial components are used for treatment of
human leishmaniasis, but treatment failures and drug resis-
tances are common (47, 48). Therefore, there is a critical need
for new drugs and drug targets, as well as vaccines.
The outer membrane of Leishmania major is covered by a
dense glycocalyx consisting predominantly of lipophosphogly-
can (LPG) and other phosphoglycan (PG)-containing mole-
cules, including proteophosphoglycans (PPG), and a heteroge-
neous group of glycoinositolphospholipids (6, 21). These
molecules are thought to be important virulence factors and
play key roles in entry, survival, and proliferation of parasites
inside host cells (11, 33, 49, 50). In vitro and in vivo studies
using purified parasite molecules have identified LPG as a
multifunctional virulence factor required for the establishment
of infections (6, 43). The roles ascribed to LPG by in vitro
testing include inhibition of complement lysis, inhibition of
phagolysosome fusion, modulation of macrophage signal trans-
duction pathways, and downregulation of the expression of
inducible nitric oxide synthase and synthesis of interleukin-12
(IL-12) (6, 10, 13, 35, 49, 50). However, because of close
structural similarities of the glycoconjugate molecules (6, 21),
there is a strong potential for cross-activity of shared domains
between LPG and other molecules. Moreover, these studies
explore LPG in an artificial context, rather than in the natural
membranous context during parasite infection (6).
To overcome these limitations, we and others have used
targeted gene inactivation to generate mutants which specifi-
cally lack the expression of one or more glycoconjugates (7, 20,
43, 45, 55). This allows dissection of the role of these molecules
in virulence in the context of the parasite in situ and their
influence on the host immune response as well. For example,
L. major mutants generated by deleting the LPG1 gene encod-
ing the putative galactofuranosyl transferase involved in the
biosynthesis of the LPG core glycan specifically lack LPG (18).
The lpg1 L. major mutant shows deficiencies in the initial
steps of the infectious cycle, including complement resistance,
phagolysosomal fusion, and macrophage survival (43, 44).
However, those parasites that go on to survive can form amas-
tigotes that are still virulent in vivo (43), consistent with the
observation that amastigotes do not express LPG. In contrast,
lpg2 parasites, generated by deleting the LPG2 gene encoding
the transporter required for GDP mannose uptake into the
Golgi lumen, lack both LPG and other PG-containing mole-
cules (27) and other potential LPG2-dependent metabolites
* Corresponding author. Mailing address: Parasite Vaccines Develop-
ment Laboratory, Department of Immunology, University of Manitoba,
730 William Avenue, Winnipeg, Manitoba R3E 0W3, Canada. Phone:
204-977-5659. Fax: 204-789-3921. E-mail: uzonna@cc.umanitoba.ca.





arch 18, 2014 by W







(8). These parasites are highly attenuated in vivo, showing
deficiencies in the early steps of promastigote survival, and fail
to induce any overt pathology in infected mice (45).
Based on the analysis of known glycoconjugates, the viru-
lence defect of lpg2 L. major has been attributed to its clear
PG deficiency by most researchers. However, our recent stud-
ies of another PG-deficient L. major mutant, obtained through
inactivation of the UDP-Gal transporters encoded by the
LPG5A and LPG5B genes (lpg5A lpg5B), question this as-
sumption. Unexpectedly, the lpg5A lpg5B mutant resembled
the lpg1 rather than the lpg2 parasites, by displaying a vir-
ulence defect when tested as promastigotes but showing nor-
mal virulence as amastigotes (7, 8). This suggests that a loss of
LPG2-dependent glycoconjugates, other than PGs, may under-
lie the virulence defect of lpg2 L. major. These data likewise
raise the possibility that PG deficiency alone may not be re-
sponsible for alterations in the immune response seen in lpg2
infections (51).
We previously showed that vaccination with lpg2 L. major
protects mice against virulent wild-type (WT) challenge (51).
In that report, we speculated the protected effect of lpg2
parasites could be related to their differential interaction with
cells of the immune system (including dendritic cells [DCs])
early after infection. Here we have investigated the early host
innate and adaptive immune responses to lpg2 parasites and
compared them to those induced by WT, lpg2 plus LPG2
gene add-back (lpg2 AB), and lpg1 parasites. Our results
show that the outcome of the lpg2 parasite interaction with
dendritic cells (DCs) and the host early immune response
against these mutants are qualitatively and quantitatively dif-
ferent from those of WT L. major. Specifically, we show that
although lpg2 L. major infection does not upregulate the
expression of costimulatory molecules on DCs, it significantly
enhanced their production of IL-12, thereby altering the host
early immune response such that the ratio of IL-4 and gamma
interferon (IFN-) production by the responding T cells is
altered. Thus, in response to infection by lpg2 L. major, the
antigen-presenting abilities of DCs are skewed toward a more
effective Th1 response.
MATERIALS AND METHODS
Mice. Female 6- to 8-wk-old BALB/c mice were purchased from GMC, Cen-
tral Animal Care Services, University of Manitoba, or from The Jackson Labo-
ratory. BALB/c ovalbumin (OVA) T-cell receptor (TCR) transgenic mice
(DO11.10) were kindly provided by Xi Yang, Department of Medical Microbi-
ology, University of Manitoba. Mice were maintained in a specific-pathogen-free
environment at the Central Animal Care Services and were used according to the
guidelines stipulated by the Canadian Council on Animal Care.
Parasite strains and infection protocol. lpg1, lpg2, lpg2 AB, and lpg5A
lpg5B mutants were derivatives of the WT L. major strain LV39 clone 5
(Rho/SU/59/P) and were made by homologous gene targeting as described pre-
viously (7, 8, 43, 45). Parasites were cultured at 26°C in M199 medium (HyClone,
Logan, UT) supplemented with 10% heat-inactivated fetal bovine serum (FBS)
(Cansera, Mississauga, Ontario, Canada), 2 mM L-glutamine, 100 U/ml penicil-
lin, and 100 g/ml streptomycin (Invitrogen Life Technologies, Burlington, On-
tario, Canada). For the lpg1, lpg2, and lpg5A lpg5B lines, selective drugs
were added to the culture media as appropriate for the selective markers used in
their construction (puromycin, 15 g/ml; G418, 15 g/ml; hygromycin B, 20
g/ml; blasticidin S, 15 g/ml).
For infection of mice, stationary-phase promastigotes (7 days postpassage)
were labeled with CFSE [5 (6-)-carboxyfluorescein diacetate succinimidyl ester]
dye (see below), washed three times in cold phosphate-buffered saline (PBS),
and resuspended in PBS at 108/ml and 50 l containing 5  106 parasites was
injected into the right hind footpad. In some experiments, mice were infected
intradermally in the ear with 5  106 parasites resuspended in 10 l PBS.
DC isolation from infected mice. After 3 days of infection, mice were sacrificed
and CD11c DCs were isolated from the draining popliteal lymph nodes (dLNs)
of mice infected with CFSE-labeled WT, lpg2, or lpg2 AB L. major as described
previously (4) with some modifications. Briefly, pooled dLNs from six to eight
mice were cut into small pieces and digested at 37°C with 1 mg/ml collagenase/
dispase (Roche Scientific, Laval, Quebec, Canada) and 50 g/ml DNase I (Sigma
Aldrich, Mississauga, Ontario, Canada) in 1 ml RPMI (Invitrogen) medium
containing 2% fetal bovine serum (Cansera). Frequent mixing at room temper-
ature for 20 min was sufficient to disperse the cells, after which 600 l of 0.1 M
EDTA (pH 7.2) was added and stirred continuously for another 5 min to break
up DC–T-cell conjugates. Undigested fibrous materials were removed by filtra-
tion through a 70-m-pore cell strainer (Falcon, VWR, Edmonton, Alberta,
Canada). The digested lymph node cell suspensions were counted, labeled with
anti-CD11c antibody-coated microbeads, and passed through an autoMACS
separator (Miltenyi Biotec, Auburn, CA) according to the manufacturer’s sug-
gested protocols. The purity of the isolated DCs was between 90 and 95%.
BMDC generation, in vitro infection and stimulation. Bone marrow cells were
isolated from the femur and tibia of WT BALB/c mice. Briefly, after depletion of
erythrocytes with ACK lysis buffer (150 M NH4Cl, 1 M KHCO3, 0.1 M
Na2EDTA, pH 7.2 to 7.4), the cells were seeded in petri dishes at 2 105/ml and
differentiated in the presence of recombinant mouse granulocyte-macrophage
colony-stimulating factor (20 ng/ml; Peprotech, Indianapolis, IN) at 37°C in a
CO2 incubator. The culture media were changed twice (on day 3 and 6), and on
day 7, the nonadherent cells (DCs) were collected for in vitro experiments. The
purity of the cells was between 85 and 92% (CD11c cells).
For infection, bone marrow-derived DCs (BMDCs) were incubated with un-
labeled or CFSE-labeled parasites for 5 h at a BMDC/parasite ratio of 1:10. The
free parasites were washed away (three washes with complete medium), and
infected cells were cultured at 37°C for 24 h. In some experiments, infected
BMDCs were stimulated with different concentrations of agonistic stimuli, in-
cluding anti-CD40 monoclonal antibody (MAb), IFN-, and lipopolysaccharide
(LPS).
CFSE labeling protocol. The CFSE labeling protocol has been described
previously (26). Briefly, single-cell suspensions from the dLNs were counted and
stained with CFSE at 1.25 M at room temperature in the dark with continuous
rocking. After 5 min, staining was quenched with heat-inactivated FBS and the
cells were washed, counted, resuspended in complete medium, and used for in
vitro cultures. For labeling parasites with CFSE, the stationary parasites were
washed three times in PBS, resuspended at 40  106/ml in PBS, and mixed with
an equal volume of 1.6 M CFSE for 5 min at room temperature.
DC and T-cell coculture experiments. T cells were purified from the spleens of
DO11.10 mice by positive selection using CD90.2-coated microbeads and the
autoMACS separator system according to the manufacturer’s suggested proto-
cols (Miltenyi) and labeled with CFSE. The infected BMDCs were pulsed with
full-length OVA protein (100 g/ml) overnight and then cocultured with CFSE-
labeled DO11.10 cells at different T-cell/DC ratios (ranging from 5:1 to 1,000:1)
for 4 days, and cell proliferation and intracellular IFN- production were as-
sessed by flow cytometry. In some experiments, infected DCs were cocultured
with a LACK-specific CD4 T-cell hybridoma expressing I-Ad (28) (LMR7.5;
kindly provided by Nicholas Glaichenhaus, Institut National de la Sante et de la
Recherche Medicale, Valbonne, France). After 3 days, proliferation and cyto-
kine production were assessed.
In vitro recall response and intracellular cytokine staining. At various times
after infection, dLNs were harvested and made into single-cell suspensions. The
cells were washed, resuspended at 4  106 cells/ml in complete medium (Dul-
becco’s modified Eagle’s medium supplemented with 10% heat-inactivated FBS,
2 mM glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin), plated at 1
ml/well in 24-well tissue culture plates (Falcon), and stimulated with soluble
leishmanial antigen (SLA; 50 g/ml) (42). After 72 h, the culture supernatants
were collected and stored at 20°C until assayed for cytokines by enzyme-linked
immunosorbent assay (ELISA). Some cells were used for intracellular cytokine
staining, as previously described (54). Briefly, cells were stimulated with 20 ng/ml
phorbol myristate acetate, 1 M ionomycin, and 10 g/ml brefeldin A (all from
Sigma) for 4 to 6 h before surface staining. Surface-stained cells were washed and
fixed with 2% paraformaldehyde and then permeabilized with 0.1% saponin
(Sigma) in staining buffer and stained with specific fluorochrome-conjugated
MAbs against IFN-, IL-4, and IL-10 (all from BD Bioscience, Mississauga,
Ontario, Canada). Samples were acquired on either a FACSCalibur or a
FACSCanto II flow cytometer (BD Bioscience) and analyzed using CellQuest
Pro software (BD Bioscience) or FlowJo software (TreeStar, Ashland, OR).
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Cytokine ELISAs. IL-4, IL-10, IL-12, and IFN- concentrations in culture
supernatant fluids were determined by sandwich ELISA using the following
antibody pairs from BioLegend (San Diego, CA): IL-12p40, C15.6 and C17.8;
IL-10, JES5-16E3 and JES5-2A5; IFN-, R4-6A2 and XMG1.2; and IL-4, 11B11
and BVD6-24G2. The sensitivities of the ELISA are as follows: IL-4, 15 pg/ml;
IL-10, 15 pg/ml; IL-12, 64 pg/ml, and IFN-, 30 pg/ml.
Real-time PCR assay. Three days postinfection, total RNA was extracted from
dLN cells using RNA Stat-60 (Tel-Test, Friendswood, TX), according to the
manufacturer’s specifications and reverse transcribed into cDNA using the RT
transcription kit (Gibco-BRL, Gaithersburg, MD). Real-time PCRs were per-
formed with the Smart Cycler II system (Cepheid, Sunnyvale, CA). PCR cycling
conditions included 2 min at 50°C, 10 min at 95°C, and then 40 cycles of 5 s at
95°C and 1 min at 60°C. The quantitative PCR was performed according to the
manufacturer’s protocol using the predeveloped TaqMan assay reagents for
murine IL-4, IL-10, IL-12p40, and IFN- genes and the SYBR green master mix
(SuperArray, Frederick, MD). Differences in starting amount of RNA or cDNA
were corrected by normalizing with -actin RNA (housekeeping gene). Data
were analyzed with the Smart Cycler software v2.0 (Cepheid). The results are
expressed as the relative increase in gene expression in infected animals over the
uninfected ones.
Statistics. Results are shown as means  standard errors. Results from each
group were compared using Student’s t test. A P value of 0.05 was considered
significant.
RESULTS
WT and lpg2 L. major induce similar pattern of expression
of costimulatory molecules but differential IL-12 production in
BMDCs. We previously showed that similar to WT, lpg2 L.
major parasites can invade macrophages but are progressively
destroyed beyond 24 h (45). DCs, which are among the first
cells infected by Leishmania (3, 40), are the most efficient
antigen-presenting cells and hence are essential for inducing
an efficient anti-Leishmania adaptive immune response (41).
To investigate the possible effect of LPG2-dependent mole-
cules on DC function, we generated BMDCs and determined
their expression of costimulatory molecules after infection with
WT and lpg2 L. major. In our initial experiments, at all times
tested, there was no difference in the expression (percent ex-
pression and mean fluorescence intensities [MFI]), of major
histocompatibility complex (MHC) class II, CD40, CD80, and
CD86 molecules by BMDCs infected with WT or lpg2 organ-
isms (data not shown). However, because the infectivity of the
DCs in our system was low (	47 to 54% for WT, lpg2 AB, and
lpg2 parasites) (Fig. 1A), we considered the possibility that
moderate changes in expression of these molecules by infected
cells may be masked by normal or enhanced expressions in
uninfected cells. Therefore, we infected the cells with CFSE-
labeled parasites and analyzed the expression of costimulatory
molecules on only infected (CFSEhigh) DCs. The percentages
of WT-, lpg2 AB-, or lpg2-infected (CFSEhigh) DCs were
comparable (Fig. 1A), suggesting that the loss of cell surface
glycoconjugates did not affect uptake of lpg2 parasites by
DCs. By focusing only on infected DCs, there was still no
difference in expression (MFI) of these molecules by WT- and
lpg2 L. major-infected BMDCs (Fig. 1B). These data suggest
that expression of LPG2-dependent glycoconjugates does
not greatly affect the expression of costimulatory molecules
on DCs.
IL-12 produced by DCs also plays a critical role in the
development of CD4 Th1 cells and resistance to L. major
infection in mice (24, 31, 34, 41). Thus, we measured the
production of IL-12p40 by BMDCs after 24 h of infection.
lpg2 L. major-infected BMDCs produced significantly (P 
0.05 to 0.01) more IL-12p40 than those infected with WT
parasites following stimulation with several IL-12-inducing
agonists, including the anti-CD40 MAb, IFN-, and LPS (Fig.
1C) (data not shown). Cells infected with lpg2 AB parasites
showed a pattern of cytokine production similar to those in-
fected with WT parasites (Fig. 1C). Interestingly, we were
unable to detect significant levels of IL-12p70 subunit by
ELISA despite the high levels of IL-12p40 subunit, as has been
previously reported (2, 17). Taken together, these results indi-
cate that although infection with lpg2 L. major did not lead to
significant alteration in the expression of costimulatory mole-
cules on DCs, they are capable of positively enhancing their
secretion of IL-12p40, a critical Th1-inducing cytokine.
Freshly isolated (ex vivo) DCs from WT- and lpg2 mutant-
infected mice express similar levels of costimulatory mole-
cules. Since we were unable to demonstrate differential effects
of WT and lpg2 parasites on the expression of costimulatory
molecules on infected DCs in vitro, we asked whether similar
effects occurred in vivo. We infected mice in the footpad with
CFSE-labeled WT, lpg2 AB, and lpg2 L. major parasites and
after 3 days purified DCs from pooled popliteal lymph nodes
draining the infection site (dLNs) and analyzed their numbers,
subsets, and expression of costimulatory molecules. Labeling
with CFSE allowed us to determine the percentages of infected
DCs and also to focus our assessment of costimulatory mole-
cule expression on only these infected cells. As expected, in-
fection with both parasite lines led to significant increase in the
number of cells recovered from the dLN (Fig. 2A). However,
there was no significant difference in the total numbers of cells
(Fig. 2A), CD11c (Fig. 2B) or CFSEhigh (i.e., infected) (Fig.
2C) DCs recovered from the dLNs of mice infected with either
parasite line, suggesting that the deficiency of PGs does not
impair the early inflammatory response, migration, and/or ex-
pansion of cells (including DCs) into the dLNs. Consistent with
the in vitro findings, we found no difference in the expression
of costimulatory molecules (MHC II, CD40, CD80, and CD86)
by directly ex vivo total or infected (CFSEhigh) DCs isolated
from mice infected with WT, lpg2 AB, or lpg2 parasites (Fig.
2D). Because the relative expression of CD8
 on DCs may
affect their ability to present Leishmania antigens and activate
Leishmania-specific T cells (19, 40), we determined whether
infection with lpg2 affected the expression of this subpopula-
tion of DCs. There was no difference in percentage or MFI
(Fig. 2E) (data not shown) of CD8
-positive DCs isolated
from dLNs of lpg2 and WT L. major-infected mice. Together
with the in vitro data, these results show that infection with
lpg2 L. major does not significantly alter the expression of
costimulatory molecules on DCs relative to that seen with WT
L. major.
DCs from lpg2 L. major-infected mice are more efficient
antigen-presenting cells than those from WT L. major-infected
mice. IL-12 is a critical cytokine that skews the development of
naïve CD4 T cells into Th1 cells. To determine if the higher
IL-12 production by lpg2-infected DCs affects their ability to
activate naïve T cells, we pulsed freshly isolated DCs from
3-day lpg2- and WT L. major-infected mice with whole-length
OVA protein overnight and then cocultured them in vitro with
CFSE-labeled OVA-specific (DO11.10) T cells for 4 days. As
shown in Fig. 3A and B, DCs from mice infected with lpg2 L.
major stimulated OVA-specific T cells to produce larger
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amounts of IL-2 and IFN- than those from WT-infected con-
trols. Interestingly and consistent with lack of differences in the
expression of costimulatory molecules (Fig. 1B and 2D), there
was no significant difference in antigen-specific proliferation of
OVA-specific T cells following presentation with OVA by DCs
from mice infected with either parasite (Fig. 3A).
To determine the relevance of the enhanced IFN- produc-
tion by DO11.10 T cells following OVA presentation by freshly
FIG. 1. L.major glycoconjugate molecules do not affect the expression of costimulatory molecules but influence IL-12 production by DCs. (A) BMDCs were
infected with CFSE-labeled WT, lpg2 AB and lpg2-deficient (lpg2) L. major stationary-phase promastigotes (BMDC/parasite ratio, 1:10), and the rate of
infection was determined after 24 h by gating on infected cells (CD11c CFSE cells). The expression of MHC class II, CD40, CD80, and CD86 on infected
(CFSE) or on total (CD11c) DCs was determined by flow cytometry. Data are presented as percent MFI of gated infected cells (B). Some uninfected and
infected BMDCs were stimulated with various concentrations of anti-CD40 and IFN- for 24 h, and the culture supernatant fluids were collected and assayed
for IL-12p40 by ELISA (C). Data presented are representative of three independent experiments with similar results. *, P  0.05; **, P  0.01.
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isolated DCs from lpg2-infected mice, we compared the abil-
ity of freshly isolated DCs from WT- or lpg2-infected mice to
activate the Leishmania-specific T-cell hybridoma, LMR7.5, in
vitro (9). LMR7.5 cells cocultured with DCs from lpg2-in-
fected mice produced more IL-2 and IFN- than those stimu-
lated with cells from WT-infected mice (Fig. 3C). Taken together,
these results indicate that the absence of glycoconjugate mole-
cules influences the expression of costimulatory molecules
and in the process modulates the antigen-presenting func-
tions of DCs.
L. major glycoconjugates regulate the host early immune
response. We previously showed that despite parasite persis-
tence, the effector T-cell response in mice infected with lpg2
parasites for 4 weeks is weak (51). This suggests that the early
immune response in lpg2-infected mice may be defective. Here
we examined the early immune response induced by lpg2, lpg2
AB, and WT parasites in the first few days postinfection. The
numbers of cells in the dLNs of mice infected with lpg2 parasites
increased at 24 h, reaching a peak at 3 days postinfection, and
were comparable to those seen in mice infected with WT. How-
ever, from day 7 postinfection, the cell numbers began to decline
in lpg2-infected mice, while the number of cells in dLNs from
WT-infected mice was sustained (Fig. 4A). Interestingly and con-
sistent with similar infectivity seen in DCs (Fig. 2C), similar num-
bers of WT and lpg2 parasites were recovered at the site of
infection on days 3 and 7 postinfection (Fig. 4B) (data not shown),
suggesting that lpg2 parasites were not rapidly destroyed by the
innate immune system.
FIG. 2. The glycoconjugate molecules of Leishmania major do not modulate DC activation in vivo. BALB/c mice infected in the footpad with
CFSE-labeled WT, lpg2 AB, or lpg2 (lpg2 knockout) L. major parasites were sacrificed at 3 days, the dLNs were collected and then digested with
collagenase, and the total number of cells was enumerated by direct cell count using a hemocytometer (A). DCs were isolated from pooled dLN
cells by positive selection using autoMACS column, and stained routinely with fluorochrome-labeled anti-CD11c MAb and other various cell
surface markers (CD40, CD80, CD86, and MHC II). The stained cells were analyzed by flow cytometry to enumerate the total number of DCs
(i.e., CD11c cells in panel B) or percentage of infected cells (i.e., CFSEhigh CD11c cells in panel C). The expression of MHC class II, CD40,
CD80, and CD86 molecules (D) and CD8
 molecules (E) on both infected (CFSEhigh) and total DCs were analyzed after gating on CD11c cells.
Data presented are representative of three (A to C) and two (D) independent experiments with similar results. ND, not done. *, P  0.05; **,
P  0.01.
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Next, we determined the early antigen-specific cytokine pro-
duction by dLNs following stimulation with SLA. Although the
levels of antigen-specific proliferation of dLN cells from lpg2
and WT L. major-infected mice were comparable at 3 days
postinfection (Fig. 4C), similar to that seen by ex vivo DC
stimulation of DO11.10 T cells (Fig. 3A), cytokine production
was dramatically different. Intracellular cytokine staining
showed that the numbers of IFN--producing cells were com-
parable, whereas the numbers of IL-4-producing (and to a
lesser degree IL-10-producing) cells in the dLNs from mice
FIG. 3. More efficient induction of IL-2 and IFN- responses by DCs from lpg2 L. major-infected mice. DCs isolated from BALB/c mice infected for 3
days with WT or lpg2 L. majorwere pulsed overnight with full-length OVA protein (100g/ml) and then cocultured with purified CFSE-labeled CD4 T cells
from DO11.10 transgenic mice. After 4 days, proliferation and IFN- production were determined by flow cytometry (A). The culture supernatant fluids were
collected and assayed for IL-2 and IFN- by ELISA (B). Some purified DCs were cocultured with a LACK-specific T-cell hybridoma (LMR7.5) for 72 h, and
the culture supernatant fluids were assayed for IL-2 and IFN-by ELISA (C). The data presented are representative of three (A and B) and two (C) independent
experiments (n  4 to 5 mice/group in panels A and B) with similar results. ND, not done. *, P  0.05; **, P  0.01.
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FIG. 4. Modulation of the host early immune response by L. major glycoconjugate molecules. BALB/c mice infected in the footpad with WT,
lpg2 AB, and lpg2 L. major were sacrificed at the indicated days, and the number of cells in the dLN was enumerated by direct cell count (A).
Parasite burden in the infected footpad was determined by limiting dilution (B). Some cells were labeled with CFSE dye and stimulated in vitro
with SLA (50 g/ml) for 3 days, and proliferation was assessed by flow cytometry (C). After 3 days of culture, some cells were stained for
intracellular production/expression of IFN-, IL-4, and IL-10 and analyzed by flow cytometry (D). The cell culture supernatants were collected and
assayed for cytokines (IL-12p40, IL-4, and IFN-) by ELISA (E to G). The data presented are representative of three to five independent
experiments (n  3 to 5 mice/group) with similar results. *, P  0.05.
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infected with lpg2 were lower than those from WT-infected
mice (Fig. 4D). Interestingly, most of the IL-4-producing cells
also coproduced IL-10 (data not shown), an important disease-
promoting cytokine in experimental cutaneous leishmaniasis.
As expected and consistent with our previous report (51), the
pattern of cytokine production by dLN cells from mice infected
with lpg2 parasites complemented with the LPG2 gene (lpg2
AB) was similar to those infected with WT parasites (Fig. 4D),
indicating that decreased IL-4 response by lpg2 parasites is
related to deficiency of PGs and not a result of the genetic
manipulation processes. This pattern of intracellular cytokine
response (normal IFN- and low IL-4 in lpg2-infected mice)
was also confirmed by ELISA (Fig. 4F and G). Furthermore,
cells from mice infected with lpg2 parasites produced more
IL-12p40 than those from WT L. major-infected mice (Fig.
4E). By day 14 postinfection, the production of IFN- and IL-4
was dramatically reduced in lpg2-infected mice (Fig. 4F and
G). This sharp decline in cytokine production parallels the
decline in parasite numbers in the footpads of lpg2-infected
mice (data not shown), suggesting that parasite number is
directly correlated with the magnitude of immune response in
infected mice.
As the route of infection with L. major influences the nature
of the immune response (5, 37), we investigated whether mod-
ulation of DC function and early host immune response by
lpg2 L. major is a general phenomenon that is independent of
route of infection. Therefore, we assessed the early immune
response in mice infected intradermally in the ear with lpg2
and WT L. major. As shown in Fig. 5A and B, the pattern of
DC activation and early cytokine response was similar to that
observed after subcutaneous (footpad) infection, such that
cells from lpg2-infected mice expressed equivalent (MHC II,
CD40, and CD86) or slightly higher (CD80) levels of costimu-
latory molecules and produced less IL-4 than those from WT-
infected mice. Taken together, these results show that infec-
tion with lpg2 parasites alters the host early immune response
toward a more robust Th1 phenotype.
Deficiency of PGs may contribute to the differences in the
early immune response in mice infected with lpg2 L. major.
As summarized in the introduction, lpg2 parasites lack all
PGs, including those attached to LPG and PPGs, which exist in
both secreted and membrane-bound forms throughout the par-
asite infectious cycle. However, recent data showed that PG
deficiency is not responsible for the amastigote virulence de-
fects of the lpg2 mutant (8), likewise raising the possibility
that PG deficiency alone may not be responsible for alterations
in the early immune response seen in lpg2 infections. To
further probe the nature of the molecule(s) responsible for the
LPG2-dependent effects on DCs in vitro and in vivo (seen
above), we made use of additional L. major mutants deficient
in various PGs through inactivation of other LPG genes and
differing in virulence from WT or lpg2 parasites.
lpg1-deficient parasites specifically lack LPG but maintain
WT levels of other PGs such as PPG (43). In vivo, parasites
involved in lpg1 infection show defects in the initial phases of
macrophage establishment, but parasites that survive go on to
form fully virulent amastigotes are able to cause progressive
lesions in susceptible BALB/c mice (43). As shown in Fig. 6A,
there was no significant alteration in the expression of costimu-
latory molecules on DCs from mice infected for 3 days with
WT, lpg1, or lpg2 L. major. In contrast, whereas the early
cytokine responses induced by lpg1 parasites were similar to
those of WT parasites (no decrease in IL-4 and IL-10 re-
sponses), the frequencies of IL-4- and IL-10-producing cells
from mice infected with lpg2 parasites were reduced (Fig.
6B), consistent with previous results (Fig. 4D and 5B). Since
the effects of lpg1 parasites in vitro and in vivo were similar to
FIG. 5. The immunomodulatory effect of L. major glycoconjugate molecules is independent of site of infection. BALB/c mice infected in the
ear (intradermal) with 5 million WT or lpg2 L. major parasites were sacrificed after 3 days, and CD11c DCs were purified from pooled dLN
cells; stained for surface expression of MHC class II, CD40, CD80, and CD86 molecules; and analyzed by flow cytometry (A). Some unfractionated
dLN cells were stimulated with SLA for 3 days, and the percentage of IFN-- and IL-4-producing cells was determined by intracellular cytokine
staining (B). The data presented are representative of two independent experiments (n  4 to 5 mice/group) with similar results.
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FIG. 6. Differences in the early immune response in mice infected with lpg2 L. major are unrelated to absence of LPG. BALB/c mice were infected in the
footpad with 5 million WT, lpg1, and lpg2 L. major stationary-phase promastigotes. After 3 days, mice were sacrificed and CD11c cells (DCs) were isolated
from pooled dLN cells; stained for surface expression of MHC class II, CD40, and CD80 molecules; and analyzed by flow cytometer (A). Some unfractionated
dLN cells were also stimulated with SLA for 3 days, and the percentage of IFN--, IL-4-, and IL-10-producing cells was determined by intracellular cytokine
staining (B). In some experiments, dLN cells from mice infected with WT, lpg2, and lpg5A lpg5B L. major for 3 days were cultured for 72 h, and the culture
supernatant fluid was assayed for IL-4 by ELSA (C). Total cellular RNA was isolated from some dLN cells and quantified by real-time PCR (D). Data presented
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those of WT parasites, it was not necessary to investigate the
effects of lpg1 AB parasites in these studies.
To confirm whether the decreased IL-4 response following
infection with lpg2 L. major was due to lack of PGs or related
to PG-associated loss of virulence, we examined IL-4 produc-
tion in infections by the lpg5A lpg5B L. major mutant
(lpg5), which lacks all PGs due to inactivation of the para-
site’s Golgi UDP-Gal transporters (7), yet show virulent char-
acteristics similar to lpg1 L. major (7, 8). As shown in Fig. 6C
and D, both IL-4 message and protein were suppressed two- to
threefold in mice infected with lpg2 and lpg5 L. major,
suggesting that the absence of PG molecules and not lack of
virulence was primarily responsible for the decrease in IL-4
response in mice infected with lpg2 L. major.
DISCUSSION
The primary aim of this study was to determine whether
there are differences in the early immune responses to WT and
lpg2 L. major that could help account for the protection
observed in mice vaccinated with lpg2 parasites (51). We
investigated the early immune response and DC functions fol-
lowing infection with WT and lpg2 L. major. First we focused
on the expression of costimulatory molecules and antigen pre-
sentation by DCs. We found that WT and lpg2 L. major
induced comparable expression of costimulatory molecules on
infected DCs in vitro and in vivo. After 3 days, infection with
both WT and lpg2 parasites did not lead to appreciable
changes in the expression of MHC class II and other costimu-
latory molecules, including CD40, CD80, and CD86 on total
DCs isolated from the dLNs of infected mice. However, these
molecules were upregulated equally on the minor population
(	10%) of infected DCs, suggesting that LPG2-dependent
PG-containing molecules do not alter the expression of co-
stimulatory molecule expression on DCs. Interestingly, infec-
tion with the specifically LPG-deficient lpg1 mutant also
failed to induce any significant changes in the expression of
costimulatory molecules on DCs (Fig. 6A). Quantitative stud-
ies show that in promastigotes, LPG constitutes well over 90%
of the parasite PGs in the L. major line studied here (43). The
present study suggests that neither LPG- nor PG-containing
molecules play any significant role in altering the expression of
costimulatory molecules on DCs.
Functional antigen presentation studies showed that lpg2-in-
fected DCs exhibited an increased ability to present a test
antigen (OVA) relative to those infected with WT parasites as
manifested by increased production of IL-2 and IFN- by
OVA-specific T cells. Since infection with lpg2 L. major did
not alter the expression of costimulatory molecules on infected
DCs, the results suggest that the increased Th1 response fol-
lowing lpg2 L. major infection may not be related to a more
efficient T-cell activation resulting from interaction of more
costimulatory molecules with their ligands, which leads to
stronger signals on T cells. However, it is conceivable that
altered T-cell response could also occur from altered antigen
presentation that could have arisen through other LPG2-de-
pendent effects such as transient delay in the formation of
fusogenic phagolysosomes (10, 12, 13). However, because full-
length OVA used in our studies should be taken up mostly by
endocytosis, it is likely that altered phagolysosomal fusion in
lpg2 mutant-infected cells may not have significantly affected
the rate of antigen processing in this system. Therefore, the
exact mechanism through which DCs from lpg2-infected mice
enhanced IFN- response without affecting proliferation re-
mains unknown.
Previous reports showed that the LACK antigen is mostly
released, processed, and presented to T cells by macrophages
only following internalization of parasites with reduced infec-
tivity that are subsequently killed (9, 38). This raises the pos-
sibility that the increased presentation of LACK observed by
DCs from lpg2-infected mice could reflect a superior killing
of the mutant parasites. However, we were only able to recover
about 1% of the infecting parasite dose (close to 	5  104)
(Fig. 4B) after 3 days postinfection with WT and lpg2 para-
sites, indicating that greater than 95% of the infecting parasites
are killed within few hours or days of infection. This high and
similar rate of early destruction of WT and lpg2 parasites
suggests that levels of release of LACK in mice infected with
WT and lpg2 parasites may be similar. Therefore, it is un-
likely that the increased presentation of LACK and induction
of higher IFN- and IL-2 production by lpg2 mutant-infected
DCs over WT-infected cells are related to faster killing of
lpg2 parasites after infection. Another important consider-
ation is that differences between WT and lpg2 parasites could
reflect differences in infectivity since unselected stationary-
phase promastigotes used here may contain different numbers
of infective metacylic promastigotes. However, given that our
studies and analyses concentrated on the early phase of infec-
tion (3 days postinfection), when there was no difference in
both the percentage of infected DCs and parasite burden in
WT- and lpg2 mutant-infected mice (Fig. 2B and 4B), we
believe the use of unselected parasites in these studies has not
significantly affected the results and their interpretation.
A previous report showed that LPG of L. major negatively
modulates the expression of costimulatory molecules on Lang-
erhan cells (a subtype of DCs) and inhibits their migratory
activities (36). However, since this report was based on studies
using purified LPG, its biological relevance is difficult to assess.
In contrast, a recent report suggests a critical role for Leish-
mania mexicana LPG in the upregulation of costimulatory
molecules (CD40, MHC class II, and CD80) on DCs (1). In-
terestingly, the complementary add-backs were unable to re-
store the WT phenotype on infected cells. We found that like
WT L. major, both lpg1 and lpg2 L. major infections of DCs
altered the expression of costimulatory molecules to the same
extent over basal levels seen in uninfected cells. These differ-
ences in observation may be related to the use of different
Leishmania species (L. mexicana versus L. major). For in-
stance, the ability of Leishmania to induce IL-12 production by
DCs has been shown to vary depending on the parasite species
(16, 29, 30). Furthermore, while lpg2 L. major parasites are
highly attenuated (44, 45), lpg2 L. mexicana parasites retain
amastigote virulence (20). It is conceivable that different spe-
cies of Leishmania may use different mechanisms to subvert
the host immune response. Interestingly, infection of DCs with
lpg2 L. major significantly enhanced their production of IL-
12p40 in response to various DC-stimulating agonists (Fig.
1C). Thus, while the glycoconjugate molecules of L. major do
not influence DC expression of costimulatory molecules, they
may act to prevent their effective antigen presentation capacity




arch 18, 2014 by W







(in an as yet undetermined way), thereby affecting their effec-
tor Th1 cell-inducing abilities.
In addition to antigen processing and presentation, DCs also
influence the nature of immune response by producing cyto-
kines including IL-12. While in vitro infection of DCs with WT
L. major resulted in minimal production of IL-12p40 over basal
levels, infection with lpg2 L. major resulted in a more than
180% increase in IL-12p40 production (Fig. 1C). This differ-
ence in IL-12 production between WT and lpg2 L. major-
infected DCs persisted following stimulation with various stim-
uli, including anti-CD40, IFN-, and LPS (Fig. 1C) (data not
shown). Similar effects were seen in vivo, where IL-12p40 pro-
duction by cells from the dLNs of mice infected with lpg2 L.
major was higher than those from infected with WT parasites
(Fig. 4F). Despite the high production of the IL-12p40 subunit,
we were unable to detect measurable amounts of the bioactive
IL-12p70, as has been reported by others (2, 17). Since the p40
subunit is common to both IL-12 and IL-23, we could not rule
out the possibility that some of the molecules detected in this
study are components of IL-23. Consistent with the DC find-
ings, cells from the dLN of mice infected for 3 days with lpg2
parasites produced smaller amounts of macrophage-deactivat-
ing cytokines (IL-4/IL-10) than those from WT-infected mice
(Fig. 4D, 5B, and 6B and C). Interestingly, infection with
LPG-deficient lpg1 parasites did not lead to reduction in IL-4
production by dLN cells (Fig. 6B), whereas infection with PG-
deficient lpg5A lpg5B parasites (which lack PGs similar to
lpg2 parasites) also led to reduction of the early IL-4 response
in the dLN (Fig. 6C and D). Surprisingly, the reduced IL-4
response in mice infected with lpg2 parasites was not associ-
ated with a concomitant increase in IFN- production, a cyto-
kine that has been shown to suppress the production of IL-4 by
T cells (32). Wang et al., (53) showed that IL-12 could directly
downregulate IL-4 in the absence of IFN-. Thus, it is possible
that higher IL-12 production by cells from lpg2-infected mice
directly suppress IL-4 response, in an IFN--independent man-
ner. These results suggest that the PGs play important role in
regulating early IL-4 and IL-12p40 responses following infec-
tion with L. major. It should be emphasized that these data do
not completely rule out a role for LPG in this process; how-
ever, if active, its role is fully redundant with that of other PGs
unaffected in the lpg1 mutant. Furthermore, we do not know
whether the reduced IL-4 levels in cultures of cells from lpg2
L. major-infected mice was related to suppression or inhibition
of IL-4 production in the absence of PG-containing molecules.
The contributions of PGs and other LPG2-dependent mol-
ecules in modulating the host immune response, particularly in
the induction of protective IFN- and pathogenic IL-4 re-
sponses, have not been investigated. The early immune re-
sponse to L. major in mice is dominated by a unique population
of V4 V
8 CD4 T cells recognizing the immunodominant
epitope of LACK protein (22, 23, 25, 46). These MHC class
II-restricted cells rapidly expand in the dLNs, accumulate IL-4
transcripts within hours after infection, and secrete high levels
of this cytokine in vivo and in vitro (22, 25). The reduction in
IL-4 production in mice infected with lpg2 and lpg5A lpg5B
parasites closely mimics the failure to produce an early IL-4
burst in mice made tolerant to LACK by transgenic expression
(23). Thus, it is tempting to suggest that the PG-containing
molecules of L. major influence the host immune response to
LACK protein. Recently, LACK TCR transgenic (ABLE)
mice on a BALB/c background (39) were developed and used
to study the T-cell response to LACK protein (52). These mice
will be valuable for studying the influence of PG-containing
molecules on the induction of V4 V
8 CD4 T cells and
early IL-4 burst during L. major infection.
Overall, our results show that PGs and/or LPG2-dependent
glycoconjugate molecules of L. major are responsible for the
reduction in the production of IL-12p40 by infected DCs and
the consequent induction of increased Th1 cell response. Thus,
in addition to their role in subverting macrophage function, the
glycoconjugates of Leishmania major influence the initial path-
ways that lead to effective T-cell activation, thereby ensuring
optimal survival of the parasites in infected host. We speculate
that reduction of IL-4 (and to some extent IL-10) response in
mice infected with lpg2 L. major could lead to a more efficient
IFN--mediated activation of macrophages and DCs, leading
to rapid early parasite control. The protection induced by
lpg2 parasites is striking despite the absence of a large IFN-
response (51). Our results suggest that one reason underlying
this phenomenon is the possibility of a heightened early im-
mune response to the lpg2 parasites due to the absence of
PGs and LPG, in conjunction with the inability of this parasite
to induce lesion pathology.
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